Covid-19 might not go away but no major outbreak likely in India: Expert

It is unlikely that Covid-19 will be completely eliminated but there seems little chance of a significant outbreak of the disease in India in the next two months

coronavirus
Photo: Bloomberg
Press Trust of India Srinagar
2 min read Last Updated : Dec 30 2022 | 1:44 PM IST

It is unlikely that Covid will be completely eliminated but there seems little chance of a significant outbreak of the disease in India in the next two months, a top infectious diseases expert said on Friday.

The remarks of Dr Parvaiz Koul, director of the SKIMS Hospital in Kashmir, came in the backdrop of the highly transmissible Omicron strains, mostly BF.7, causing a spike in coronavirus cases in many countries, including China.

"It is uncertain when or if Covid will become an endemic, but it is unlikely that it will be completely eliminated. We may see occasional outbreaks, if new mutations emerge, like in China. In India, it seems unlikely that there will be a significant new outbreak in the next two-three months," Koul, a leading pulmonologist and researcher on infectious diseases, said.

Taking to Twitter, Koul said India had an advantage in dealing with Covid due to widespread hybrid immunity but suggested that the high-risk group might have to go for a booster dose.

There is an "advantage due to widespread hybrid immunity, although those at high risk might require an booster if significant time has elapsed from the last dose", he said.

"Those who haven't taken the precautionary (booster) dose, must. Watch for government guidelines," Koul said.

Earlier this week, Koul had said modelling data from credible agencies do not foresee any major Covid wave in Jammu and Kashmir.

"Modelling data from credible agencies (such as from the University of Washington) predict a low circulation of the virus for coming weeks in J&K (Jammu and Kashmir), but models can go horribly wrong," he had said.

"So stay calm, observe routine precautions and vaccinate if you haven't, as per the advisories. Safety saves. Better safe than sorry," the SKIMS Hospital's director had said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Tests

First Published: Dec 30 2022 | 1:44 PM IST

Next Story